HIV

The American Journal of Medicine has published a new article that describes the reemergence of neurosyphilis and identifies HIV coinfection in individuals in Western countries as a key risk factor.

The American Journal of Medicine has published a new article that describes the reemergence of neurosyphilis, and identifies HIV coinfection in individuals in Western countries as a key risk factor.

New study results indicate that an experimental mosaic HIV vaccine may have the potential to protect against a wide-range of global HIV strains.

Study suggests that super receptors on immune cells can eliminate HIV among genetically diverse patients.

Between 33% and 38% of youth living with HIV use tobacco.

Tobacco is the leading cause of premature mortality among adults living with HIV.

Top news of the week from Specialty Pharmacy Times.

The study emphasizes the need for harm reduction interventions that include access to syringes and sterile injection equipment, in addition to comprehensive HIV prevention services.

Researchers at the University of Virginia developed an app called PositiveLinks to test out whether interactive smartphone functions and reminders could have a real-world impact on the health of HIV-positive patients.

African Americans are more likely to be diagnosed with HIV compared with other groups, according to an analysis published in the Journal of Racial and Ethnic Health Disparities.

Although HIV diagnoses have dropped across every population in the United States, African Americans remain disproportionately affected by HIV.

National HIV Testing Day, designated by the CDC, aims to encourage individuals to know their status.

Carl Grunfeld, MD, PhD, explains the importance of pharmacists in treating patients with diabetes and HIV, and how they can help them manage these conditions better.

The CDC designated Wednesday, June 27 as National HIV Testing Day, to raise awareness for HIV infection testing, and early diagnosis.

Carl Grunfeld, MD, PhD, from the University of California San Francisco School of Medicine discusses what lifestyle modifications patients can make to manage their HIV and Diabetes.

Many individuals at high risk of getting HIV—including those who inject drugs, gay and bisexual men, and partners of people with HIV—are not screened annually and experience delays in diagnosis.

Risk factor modification remains key to managing patients with HIV and diabetes.

In this video, Priscilla Hsue, MD, from the University of California San Francisco School of Medicine, explains other health issues patietns with HIV may face as they age.

Motivational interviewing—a patient-centered method to enhance intrinsic motivation by exploring, and resolving ambivalence—has gained a good reputation for increasing adherence.

A 2-part trial shows a new antibody that suppresses HIV when combined with antiretroviral therapy (ART).

Despite universal access to care afforded to US military service members, there is a need to improve and expand access to PrEP for those patients at highest risk for HIV infection.

On National HIV Testing Day, which takes place on June 27, Walgreens and Greater Than AIDS will team up with over 200 health and community organizations to provide free HIV testing and information at Walgreens stores in over 180 cities.

As a result of the persistent opioid epidemic, a current harm reduction initiative focuses on reducing adverse consequences in drug users.

Individuals who inject drugs are at an increased risk of developing invasive methicillin-resistant Staphylococcus aureus (MRSA).

Among HIV-positive women with diabetes, HIV control has improved over time, but diabetes control has not.

When individuals who are at risk for HIV use PrEP, and use it appropriately, risk of infection is significantly lowered.

Top news of the day from across the health care landscape.

A look at last week's top stories in the world of pharmacy.

New research investigates whether reducing the pill burden in HIV treatment regimens could improve patient adherence, retention in care, and virologic outcomes.

Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses HIV and oncology distinction programs and how these standards bring patients, physicians, and pharmacists together to align care.